142 related articles for article (PubMed ID: 3148514)
41. [Short-term result of non-Hodgkin's lymphoma treated by the COMP regimen].
Tang WY; He GF; Din GX; Sun ZY
Zhonghua Zhong Liu Za Zhi; 1987 Mar; 9(2):140-2. PubMed ID: 3652916
[TBL] [Abstract][Full Text] [Related]
42. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
[TBL] [Abstract][Full Text] [Related]
43. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
Kosmas C; Malamos NA; Antonopoulos MJ
N Engl J Med; 1998 Nov; 339(20):1476; author reply 1477. PubMed ID: 9841319
[No Abstract] [Full Text] [Related]
44. Phase II study of cyclophosphamide (C), epirubicin (E), oncovin (O), prednisone (P), methotrexate (M) + leucovorin and bleomycin (B) (CEOP-MB) in intermediate and high grade non-Hodgkin lymphomas.
Wils J; Smeets J
J Chemother; 1991 Aug; 3(4):260-3. PubMed ID: 1723424
[TBL] [Abstract][Full Text] [Related]
45. CEOP regimen in the treatment of advanced low-grade non-Hodgkin's lymphomas: preliminary report.
Zinzani PL; Mazza P; Gherlinzoni F; Zanchini R; Bocchia M; Aitini E; Cavazzini G; Amurri B; Gobbi M; Tura S
Tumori; 1990 Dec; 76(6):533-6. PubMed ID: 2284688
[TBL] [Abstract][Full Text] [Related]
46. Comparison of CHOP-B vs CEOP-B in 'poor prognosis' non-Hodgkin's lymphomas. A randomized trial.
De Lena M; Maiello E; Lorusso V; Brandi M; Calabrese P; Romito S; Mazzei A; Marzullo F
Med Oncol Tumor Pharmacother; 1989; 6(2):163-9. PubMed ID: 2473364
[TBL] [Abstract][Full Text] [Related]
47. Primary non-Hodgkin's lymphoma of the larynx treated only by chemotherapy.
Blatsios V; Bouros D; Emmanouel A; Niotis M
Chest; 1990 Dec; 98(6):1547. PubMed ID: 2245721
[No Abstract] [Full Text] [Related]
48. Combination chemotherapy including epirubicin for the management of non-Hodgkin's lymphoma.
Al-Ismail SA; Whittaker JA; Gough J
Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1379-84. PubMed ID: 3315698
[TBL] [Abstract][Full Text] [Related]
49. CEOP treatment results and validity of the International Prognostic Index in Chinese patients with aggressive non-Hodgkin's lymphoma.
Chim CS; Kwong YL; Lie AK; Lee CK; Liang R
Hematol Oncol; 1998 Sep; 16(3):117-23. PubMed ID: 10235070
[TBL] [Abstract][Full Text] [Related]
50. [Problems of cancer treatment in the elderly from the viewpoint of the chemotherapist--focusing on malignant lymphomas as a model of chemotherapy].
Oyama A; Suzuki H; Ogura M
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):858-61. PubMed ID: 2188607
[No Abstract] [Full Text] [Related]
51. Cyclophosphamide, mitoxantrone, vincristine and prednisone in the treatment of non-Hodgkin's lymphoma.
Vorobiof DA; Terblanche AP; Falkson CI; Falkson G
Oncology; 1988; 45(5):378-9. PubMed ID: 3412747
[TBL] [Abstract][Full Text] [Related]
52. High-dose intensity cyclophosphamide, epidoxorubicin, vincristine and prednisone by shortened intervals and granulocyte colony-stimulating factor in non-Hodgkin's lymphoma: a phase II study.
Pronzato P; Lionetto R; Botto F; Pensa F; Tognoni A
Br J Cancer; 1998 Sep; 78(6):777-80. PubMed ID: 9743300
[TBL] [Abstract][Full Text] [Related]
53. [Phase III study of chemotherapy in low-malignancy non-Hodgkin's lymphomas: comparison of vincristine-vindesine combination chemotherapy].
Heim ME; Fritze D; Ho AD; Mebes W; Abel U
Onkologie; 1987 Dec; 10(6):345-8. PubMed ID: 3327022
[TBL] [Abstract][Full Text] [Related]
54. Generalized granuloma annulare and non-Hodgkin's lymphoma.
Bassi A; Scarfi F; Galeone M; Arunachalam M; Difonzo E
Acta Derm Venereol; 2013 Jul; 93(4):484-5. PubMed ID: 23250047
[No Abstract] [Full Text] [Related]
55. [Non-Hodgkin's lymphoma of the uterine cervix].
Plewicka M; Szelc S; Smok-Ragankiewicz A; Wojcieszek A; Szkita D
Ginekol Pol; 1995 Apr; 66(4):246-8. PubMed ID: 8529943
[No Abstract] [Full Text] [Related]
56. Acute myocardial infarction in man treated with epirubicin for non-Hodgkin lymphoma.
Aydiner A; Buğra Z; Topuz E; Meriç M
Am J Clin Oncol; 1995 Oct; 18(5):444-8. PubMed ID: 7572766
[TBL] [Abstract][Full Text] [Related]
57. [Hypersalivation as a leading symptom of neoplastic meningiosis in highly malignant non-Hodgkin's lymphoma].
Heider A; Engels B; Hartmann-Klosterkötter U; Kress M; Niederle N
Dtsch Med Wochenschr; 1993 Jan; 118(1-2):19-22. PubMed ID: 8420769
[TBL] [Abstract][Full Text] [Related]
58. Alternation of epirubicin and mitoxantrone in CHOP-like regimens retains efficacy and reduces overall toxicity in elderly patients with high and intermediate grade non-Hodgkin lymphomas.
Milone G; Di Raimondo F; Gioi FL; Palumbo GA; Manenti GO; Pafumi M; Giustolisi R
Leuk Lymphoma; 2002 Dec; 43(12):2319-24. PubMed ID: 12613518
[TBL] [Abstract][Full Text] [Related]
59. Total body irradiation and cyclophosphamide, vincristine, prednisone in the treatment of favorable prognosis non-Hodgkin's lymphomas.
Leimert JT; Corder MP; Tewfik HH; Guthrie R; Maguire LC; Gingrich RD
Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1479-83. PubMed ID: 583417
[No Abstract] [Full Text] [Related]
60. Remitting seronegative symmetrical synovitis with pitting edema syndrome associated with non-Hodgkin's lymphoma: a case report.
Sayarlioglu M; Bayram I; Sayarlioglu H; Erkoc R
Clin Rheumatol; 2004 Apr; 23(2):188-9. PubMed ID: 15045643
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
